In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice

Digestive Diseases and Sciences

Volumn 49, Issue 4, 2004, Pages 579-589

  Griffiths, Elizabeth A ^a   Duffy, Linda C ^a,d   Schanbacher, Floyd L ^b   Qiao, Haiping ^a   Dryja, Diane ^a   Leavens, Allen ^a   Rossman, Jon ^a   Rich, Gary ^a   Dirienzo, Douglas ^c   Ogra, Pearay L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c National Dairy Council   (United States)

^d CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Bifidobacteria; Endotoxin; Lactoferrin; Mucosal immunity; Probiotics

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 6; IRON; LACTOFERRIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BIFIDOBACTERIUM; CECUM; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; FEEDING; FLOW CYTOMETRY; ILEUM; IN VIVO STUDY; INTESTINE; LIMULUS LYSATE TEST; MEASUREMENT; MOUSE; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STIMULATION; T LYMPHOCYTE; TIME; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; BREEDING; COMPARATIVE STUDY; CULTURE TECHNIQUE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PREGNANCY; PROBABILITY; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; CULTURE TECHNIQUES; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-6; INTESTINAL MUCOSA; INTESTINES; LACTOFERRIN; LIMULUS TEST; MICE; MICE, INBRED BALB C; PREGNANCY; PREGNANCY, ANIMAL; PROBABILITY; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942717102     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000026302.92898.ae     Document Type: Article

References (73)

1. Fuller R: Probiotics in man and animals. A review. J Appl Bacteriol 66:365-378, 1989
2. Sanders ME: Summary of the conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures. J Dairy Sci 76:1819-1828, 1993
3. Jiang T, Mustapha A, Savaiano DA: Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum. J Dairy Sci 79:750-757, 1996
4. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H: Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32:141-144, 1992
5. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A: Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78:491-497, 1995
6. Perdigon G, Alvarez S, Rachid M, Aguero G, Gobbato N: Immune system stimulation by probiotics. J Dairy Sci 78:1597-1606, 1995
7. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH: Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046-1049, 1994
8. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ: Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135:564-568, 1999
9. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikotajczyk W: Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138:361-365, 2001
10. Reid G: Probiotics in the treatment of diarrheal diseases. Curr Infec Dis Rep 2:78-83, 2000
11. de Roos NM, Katan MB: Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998. Am J Clin Nutr 71:405-411, 2000
12. Kopp-Hoolihan L: Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 101:229-238, 2001
13. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I: Functional food science and gastrointestinal physiology and function. Br J Nutr 80(Suppl):S147-S171, 1998
14. Ziemer CJ, Gibson GR: An overview of probiotics, prebiotics and synbiotics in the functional food concept-perspectives and future strategies. Int Dairy J 8:473-479, 1998
15. Kailasapathy K, Chin J: Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78:80-88, 2000
16. Orrhage K, Nord CE: Bifidobacteria and Lactobacilli in human health. Drags Exp Clin Res 26:95-111, 2000
17. Rolfe RD: The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130(Suppl):396S-402S, 2000
18. Sanders ME: Considerations for use of probiotic bacteria to modulate human health. J Nutr 130(Suppl):384S-390S, 2000
19. Lonnerdal B, Iyer S: Lactoferrin: Molecular structure and biological function. Annu Rev Nutr 15:93-110, 1995
20. Nuijens JH, van Berkel PH, Schanbacher FL: Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia 1:285-294, 1996
21. Sanchez L, Calvo M, Brock JH: Biological role of lactoferrin. Arch Dis Child 67:657-661, 1992
22. Chierici R, Vigi V: Lactoferrin in infant formulae. Acta Paediatr Suppl 402:83-88, 1994
23. Brock JH: Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. Arch Dis Child 55:417-421, 1980
24. Bullen JJ: Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad Med J 51(Suppl):67-70, 1975
25. Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ: Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation. Infect Immun 35:792-799, 1982
26. Ellison RT III, Giehl TJ, LaForce FM: Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774-2781, 1988
27. Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH: Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628-2632, 1994
28. Griffiths E, Duffy LC, Schanbacher FL, Dryja D, Leavens A, Neiswander RL, Qiao H, DiRienzo D, Ogra P: In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin. Dig Dis Sci 48:1324-1332, 2003
29. Karch H, Bielazewska M, Bitzan M, Schmidt H: Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn Microbiol Infect Dis 34:229-243, 1999
30. Petschow BW, Talbott RD: Growth promotion of Bifidobacterium species by whey and casein fractions from human and bovine milk. J Clin Microbiol 28:287-292, 1990
31. Petschow BW, Talbott RD: Response of Bifidobacterium species to growth promoters in human and cow milk. Pediatr Res 29:208-213, 1991
32. Hentges DJ, Marsh WW, Petschow BW, Thal WR, Carter MK: Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J Pediatr Gastroenterol Nutr 14:146-152, 1992
33. Debbabi H, Dubarry M, Rautureau M, Tome D: Bovine lactoferrin induces both mucosal and systemic immune response in mice. J Dairy Res 65:283-293, 1998
34. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J: Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 79:583-593, 2000
35. Wang WP, Iigo M, Sato J, Sekine K, Adachi I, Tsuda H: Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jap J Cancer Res 91:1022-1027, 2000
36. Strober W, Kelsall B, Marth T: Oral tolerance. J Clin Immunol 18:1-30, 1998
37. Brandtzaeg P: History of oral tolerance and mucosal immunity. Ann NY Acad Sci 778:1-27, 1996
38. Mayer L: Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 30:S4-S12, 2000
39. Duffy EC: Interactions mediating bacterial translocation in the immature intestine. J Nutr 130(Suppl):432S-436S, 2000
40. Lu E, Walker WA: Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 73(Suppl):1124S-1130S, 2001
41. Bishop JG, Schanbacher FE, Ferguson LC, Smith KL: In vitro growth inhibition of mastitis-causing coliform bacteria by bovine apo-lactoferrin and reversal of inhibition by citrate and high concentrations of apo-lactoferrin. Infect Immun 14:911-918, 1976
42. Mazurier J, Spik G: Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta 629:399-408, 1980
43. Duffy LC, Zielezny MA, Carrion V, Griffiths E, Dryja, D, Hilty, M, Cummings J, Morin F III: Bacterial toxins and enteral feeding of premature infants at risk for necrotizing enterocolitis. Am J Human Biol 10:211-219, 1998
44. Duffy EC, Leavens A, Griffiths E, Dryja D: Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health. Dig Dis Sci 44:1499-1505, 1999
45. Duffy LC, Riepenhoff-Talty M, Byers TE, La Scolea LJ, Zielezny MA, Dryja DM, Ogra PL: Modulation of rotavirus enteritis during breast-feeding. Implications on alterations in the intestinal bacterial flora. Am J Dis Child 140:1164-1168, 1986
46. Stark PL, Lee A: The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 15:189-203, 1982
47. Yoshioka H, Iseki K, Fujita K: Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72:317-321, 1983
48. Benno Y, Sawada K, Mitsuoka T: The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 28:975-986, 1984
49. Gibson GR, Beatty ER, Wang X, Cummings JH: Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108:975-982, 1995
50. Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F, Rambaud JC: Short chain fructooligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 129:113-116, 1999
51. Roberts AK, Chierici R, Sawatzki G, Hill MJ, Volpato S, Vigi V: Supplementation of an adapted formula with bovine lactoferrin: 1. Effect on the infant faecal flora. Acta Paediatr 81:119-124, 1992
52. Petschow BW, Talbott RD, Batema RP: Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J Med Microbiol 48:541-549, 1999
53. Walker WA, Duffy LC: Diet and bacterial colonization: role of probiotics and prebiotics. J Nutr Biochem 9:668-675, 1998
54. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM: Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk uptake. FEMS Immunol Med Microbiol 10:55-63, 1994
55. Ogata T, Kingaku M, Yaeshima T, Teraguchi S, Fukuwatari Y, Ishibashi N, Hayasawa H, Fujisawa T, Iino H: Effect of Bifidobacterium longum BB536 yogurt administration on the intestinal environment of healthy adults. Microb Ecol Health Dis 11:41-46, 1999
56. Silva M, Jacobus NV, Deneke C, Gorbach SL: Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 31:1231-1233, 1987
57. Gibson GR, Wang X: Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412-420, 1994
58. Meurman JH, Korhonen AH, Salminen S: Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro. Eur J Oral Sci 103:253-258, 1995
59. El-Nezami H, Polychronaki N, Salminen S, Mykkanen H: Binding rather than metabolism may explain the interaction of two food-grade Lactobacillus strains with zearalenone and its derivative (') alpha-earalenol. Appl Environ Microbiol 68:3545-3549, 2002
60. Lee YK, El-Nezami H, Haskard CA, Gratz S, Puong KY, Salminen S, Mykkanen H: Kinetics of adsorption and desorption of aflatoxin B1 by viable and nonviable bacteria. J Food Prot 66:426-430, 2003
61. Teraguchi S, Ozawa K, Yasuda S, Shin K, Fukuwatari Y, Shimamura S: The bacteriostatic effects of orally administered bovine lactoferrin on intestinal Enterobacteriaceae of SPF mice fed bovine milk. Biosci Biotechnol Biochem 58:482-487, 1994
62. Ogata T, Teraguchi S, Shin K, Kingaku M. Fukuwatari Y, Kawase K, Hayasawa H, Tomita M: The mechanism of in vivo bacteriostasis of bovine lactoferrin. Adv Exp Med Biol 443:239-246, 1998
63. Duffy LC, Zielezny MA, Carrion V, Griffiths E, Dryja D, Hilty M, Rook C, Morin F III: Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis. Dig Dis Sci 42:359-365, 1997
64. Bernet MF, Brassart D, Neeser JR, Servin AL: Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 59:4121-4128, 1993
65. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Rossman J, Ogra PL: Effectiveness of Bifidobacterium bifidum in experimentally induced MRV infection: Dietary implications in formulas for newborns. Endoer Regul 27:223-229, 1993
66. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Dryja D, Sayahtaheri-Altaie S, Griffiths E, Ruffin D, Barrett H, Rossman J, Ogra PL: Effectiveness of Bifidobacterium bifidum in mediating the clinical course of murine rotavirus diarrhea. Pediatr Res 35:690-695, 1994
67. Ouwehand AC, Isolauri E, Kirjavainen PV, Salminen SJ: Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol Lett 172:61-64, 1999
68. Park SY, Ji GE, Ko YT, Jung HK, Ustunol Z, Pestka JJ: Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int J Food Microbiol 46:231-241, 1999
69. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK: Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83:167-176, 2000
70. Strobel S, Mowat AM: Immune responses to dietary antigens: Oral tolerance. Immunol Today 19:173-181, 1998
71. Husby S: Normal immune responses to ingested foods. J Pediatr Gastroenterol Nutr 30:S13-S19, 2000
72. Qiao H, Duffy LC, Griffiths E, Dryja D, Leavens A, Rossman J, Rich G, Riepenhoff-Talty M, Locniskar M: Immune responses in Rhesus rotavirus-challenged Balb/c mice treated with bifidobacteria and prebiotic supplements. Pediatr Res 51:750-755, 2002
73. Perdigon G, Alvarez S, Pesce de Ruiz Holgado A: Immunoadjuvant activity of oral Lactobacillus casei: Influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 58:485-496, 1991